Status:
COMPLETED
SCT in Ph Positive Acute Lymphoblastic Leukemia
Lead Sponsor:
CANDONI ANNA
Collaborating Sponsors:
Gruppo Italiano Trapianto di Midollo Osseo
Conditions:
Philadelphia Positive Acute Lymphoblastic Leukemia
SCT
Eligibility:
All Genders
18+ years
Brief Summary
This study includes a registry-based, nationwide analysis to describe the clinical outcome of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) who underwent ...
Detailed Description
This was a retrospective nationwide analysis based on registry data collected by GITMO. Inclusion criteria were: 1) diagnosis of Ph+ ALL; age ≥18 years at transplant; 2) patients receiving first allog...
Eligibility Criteria
Inclusion
- Diagnosis of Ph+ ALL; age ≥18 years at transplant.
- Patients receiving first allogeneic HSCT from any donor (HLA-identical sibling donor (MSD), unrelated donor (UD) or alternative donor (haploidentical or cord blood) between 2005 and 2016 in a GITMO center.
- TKI-based treatment prior to HSCT.
- Patients with available pre-transplant MRD status, as well as complete clinical data and outcome.
Exclusion
- All cases without one or more of inclusion criteria.
Key Trial Info
Start Date :
October 26 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2018
Estimated Enrollment :
441 Patients enrolled
Trial Details
Trial ID
NCT03821727
Start Date
October 26 2016
End Date
June 30 2018
Last Update
January 30 2019
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
GITMO Centers and GITMO CLINICAL OFFICE-AOU-IRCSS San Martino-Ge
Genova, Italy, 16132
2
University Hospital, Udine
Udine, Italy, 33100